Research ArticleClinical Studies

Pseudoprogression and MGMT Status in Glioblastoma Patients: Implications in Clinical Practice

ALESSANDRA FABI, MICHELANGELO RUSSILLO, GIULIO METRO, ANTONELLO VIDIRI, SALVATORE DI GIOVANNI and FRANCESCO COGNETTI
Anticancer Research July 2009, 29 (7) 2607-2610;

Article Information

vol. 29 no. 7 2607-2610
PMID 
19596935
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received January 27, 2009
  • Revision received April 14, 2009
  • Accepted May 5, 2009
  • Published online July 13, 2009.
Copyright & Usage 
Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. ALESSANDRA FABI1,
  2. MICHELANGELO RUSSILLO1,
  3. GIULIO METRO1,
  4. ANTONELLO VIDIRI2,
  5. SALVATORE DI GIOVANNI2 and
  6. FRANCESCO COGNETTI1
  1. 1Division of Medical Oncology, Regina Elena Cancer Institute, 00144, Rome, Italy
  2. 2Department of Neuroimaging, Regina Elena Cancer Institute, 00144, Rome, Italy
  1. Correspondence to: Alessandra Fabi, MD, Division of Medical Oncology, Regina Elena Cancer Institute, Via Elio Chianesi 53, 00144 - Rome, Italy. Tel: +39 0652665144; Fax: +39 0652665637, e-mail: alessandra.fabi{at}virgilio.it
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Pseudoprogression and MGMT Status in Glioblastoma Patients: Implications in Clinical Practice
ALESSANDRA FABI, MICHELANGELO RUSSILLO, GIULIO METRO, ANTONELLO VIDIRI, SALVATORE DI GIOVANNI, FRANCESCO COGNETTI
Anticancer Research Jul 2009, 29 (7) 2607-2610;
Twitter logo Facebook logo Mendeley logo

Jump to section